新芝生物
(920685)
| 流通市值：6.58亿 | | | 总市值：10.51亿 |
| 流通股本：5567.65万 | | | 总股本：8887.85万 |
| 报告期 | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 一、营业总收入 | 141,929,501.13 | 83,854,158.79 | 34,891,531.29 | 169,724,864.23 |
| 营业收入 | 141,929,501.13 | 83,854,158.79 | 34,891,531.29 | 169,724,864.23 |
| 二、营业总成本 | 111,978,470.48 | 68,876,287.87 | 29,363,681.61 | 129,940,626.36 |
| 营业成本 | 51,478,621.92 | 31,442,084.75 | 13,003,912.84 | 62,457,166.53 |
| 税金及附加 | 2,205,279.06 | 1,210,925.19 | 416,161.95 | 2,188,803.36 |
| 销售费用 | 26,071,033.72 | 16,238,583.1 | 6,682,766.85 | 26,301,810.67 |
| 管理费用 | 16,651,055.76 | 10,710,099.11 | 5,019,862.49 | 21,310,569.02 |
| 研发费用 | 15,655,286.19 | 9,476,454.1 | 4,398,369.45 | 18,212,037.99 |
| 财务费用 | -82,806.17 | -201,858.38 | -157,391.97 | -529,761.21 |
| 其中:利息费用 | 189,762.31 | 122,947.87 | 63,957.34 | 167,619.5 |
| 其中:利息收入 | 933,716.68 | 793,147.76 | 442,004.84 | 882,333.02 |
| 三、其他经营收益 | | | | |
| 加:公允价值变动收益 | 2,025,374.73 | 1,450,821.09 | 834,471.86 | 3,377,216.92 |
| 加:投资收益 | 1,664,371.11 | 904,942.22 | 184,017.02 | 1,901,592.31 |
| 资产处置收益 | 4,724 | - | 0 | 145,904.27 |
| 资产减值损失(新) | -1,698,757.35 | -1,058,989.41 | -854,303.58 | -3,098,757.73 |
| 信用减值损失(新) | -640,495.87 | -363,683.8 | -48,749.6 | -475,840.75 |
| 其他收益 | 6,857,476.59 | 4,971,873.21 | 3,163,285.15 | 7,316,819.61 |
| 四、营业利润 | 38,163,723.86 | 20,882,834.23 | 8,806,570.53 | 48,951,172.5 |
| 加:营业外收入 | 130,533.72 | 21,494.74 | 13,278.26 | 65,678.03 |
| 减:营业外支出 | 176,445.23 | 162,778.91 | 7,630.08 | 351,354.24 |
| 五、利润总额 | 38,117,812.35 | 20,741,550.06 | 8,812,218.71 | 48,665,496.29 |
| 减:所得税费用 | 3,562,697.94 | 1,912,413.18 | 533,037.44 | 4,966,359.65 |
| 六、净利润 | 34,555,114.41 | 18,829,136.88 | 8,279,181.27 | 43,699,136.64 |
| (一)按经营持续性分类 | | | | |
| 持续经营净利润 | 34,555,114.41 | 18,829,136.88 | 8,279,181.27 | 43,699,136.64 |
| (二)按所有权归属分类 | | | | |
| 归属于母公司股东的净利润 | 27,121,674.98 | 14,821,831.89 | 6,957,831.91 | 35,204,715.35 |
| 少数股东损益 | 7,433,439.43 | 4,007,304.99 | 1,321,349.36 | 8,494,421.29 |
| 扣除非经常损益后的净利润 | 22,483,533.96 | 11,567,448.12 | 4,785,518.62 | 29,070,801.85 |
| 七、每股收益 | | | | |
| (一)基本每股收益 | 0.31 | 0.17 | 0.08 | 0.4 |
| (二)稀释每股收益 | 0.31 | 0.17 | 0.08 | 0.4 |
| 九、综合收益总额 | 34,555,114.41 | 18,829,136.88 | 8,279,181.27 | 43,699,136.64 |
| 归属于母公司股东的综合收益总额 | 27,121,674.98 | 14,821,831.89 | 6,957,831.91 | 35,204,715.35 |
| 归属于少数股东的综合收益总额 | 7,433,439.43 | 4,007,304.99 | 1,321,349.36 | 8,494,421.29 |
| 公告日期 | 2026-10-27 | 2026-08-26 | 2026-04-27 | 2026-04-27 |
| 审计意见(境内) | | | | 标准无保留意见 |